Supplementary Files
Abstract
Objective: To investigated the Frequency, pattern of Distribution of Bone Metastases in Malignant Tumors of Bone scan.
Study design: It is a descriptive study.
Place and duration of study: The study was carried out in Jahangir SON-X Diagnostic Center, Rawalpindi.
Material and Methods: 100 patients with Malignancy underwent bone scan. Findings were evaluated by nuclear medicine specialist. Data was analyzed viva SPSS v22.
Results: Among 100 patients 50 patients had positive bone scan for metastases. Most common primary site for of tumor was breast followed by prostate, unknown region, lungs, muscular tumor, ovarian, adrenal, hepato cellular carcinoma, thyroid gland, renal carcinoma, CA rectum, CA urinary bladder and CA stomach. Most common site for bone metastasis was spine followed by ribs, iliac bones, femur, sternum, skull bones, humerus and tibia. Among CA breast patients, common site of distribution of metastasis was spine followed by ribs. Among prostate CA patients’ spine is the most common site followed by ribs and illiac bones.
Conclusion: Our results showed that pattern of distribution varies from tumor to tumor. bony metastasis in CA breast are usually distribute to spine and ribs. In prostatic CA metastasis usually distribute to spine followed by ribs and illiac bones.
Keywords: Frequency, Bone Scan, Hepatocellular Carcinoma, Metastasis.
References
Abd elsalam SM, ELbadawi MA, Diab WA, Said AH, Gomaa MI. Diagnostic value of whole-body diffusion weighted imaging added to bone scan in early diagnosis of bone metastases in breast cancer patients. Egyptian Journal of Radiology and Nuclear Medicine. 2023 Jun 6;54(1):102.
Ahmed F, Shahzad A, Abbas W, Mahmood S, Hussain K, Sabir M. Pattern of bone metastasis; Central VS. Peripheral skeleton in metastatic breast carcinoma. The Professional Medical Journal. 2023 Mar 31;30(04):442-5.
Brown JE, Wood SL, Confavreux C, Abe M, Weilbaecher K, Hadji P, Johnson RW, Rhoades JA, Edwards CM, Croucher PI, Juarez P. Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations. Journal of Bone Oncology. 2021 Aug 1;29:100375.
Coleman RE, Brown J, Holen I. Bone metastases. Abeloff's Clinical Oncology. 2020 Jan 1:809-30.
Chambers AF, Naumov GN, Varghese HJ, Nadkarni KV, MacDonald IC, Groom AC. Critical steps in hematogenous metastasis: an overview. Surgical oncology clinics of North America. 2001 Apr 1;10(2):243-55.
Gera K, Kahramangil D, Fenton GA, Martir D, Rodriguez DN, Ijaz Z, Lin RY, Rogers SC, Ramnaraign BH, George TJ, Hong YR. Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study. Cancers. 2023 Oct 19;15(20):5055.
Kakhki VR, Anvari K, Sadeghi R, Mahmoudian AS, Torabian-Kakhki M. Pattern and distribution of bone metastases in common malignant tumors. Nuclear medicine review. 2013;16(2):66-9.
Kakhki VR. Positron emission tomography in the management of lymphoma. Haema. 2006;9:626-36.
Lin J, Zhang Y, Hou W, Qin Q, Galsky MD, Oh WK, Tsao CK. Evolving patterns of metastasis in renal cell carcinoma: do we need to perform routine bone imaging?. Journal of Kidney Cancer and VHL. 2021;8(4):13.
Menendez LR. Orthopaedic knowledge update musculoskeletal tumors. (No Title). 2002.
Nishimura K. Management of bone metastasis in prostate cancer. Journal of Bone and Mineral Metabolism. 2023 May 10:1-0.
Paes FM, Serafini AN. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain. InSeminars in nuclear medicine 2010 Mar 1 (Vol. 40, No. 2, pp. 89-104).
Paul D, Bhardwaj S, Chatterjee SS, Chanda A. Bone metastasis in head and neck squamous cell carcinoma–5-year experience of an Indian Cancer Institute. Nowotwory. Journal of Oncology. 2023;73(1):3-9.
Pomykala KL, Czernin J, Grogan TR, Armstrong WR, Williams J, Calais J. Total-body 68Ga-PSMA-11 PET/CT for bone metastasis detection in prostate cancer patients: Potential impact on bone scan guidelines. Journal of Nuclear Medicine. 2020 Mar 1;61(3):405-11
Ryan C, Stoltzfus KC, Horn S, Chen H, Louie AV, Lehrer EJ, Trifiletti DM, Fox EJ, Abraham JA, Zaorsky NG. Epidemiology of bone metastases. Bone. 2022 May 1;158:115783.
Seifert R, Telli T, Opitz M, Barbato F, Berliner C, Nader M, Umutlu L, Stuschke M, Hadaschik B, Herrmann K, Fendler WP. Unspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer. Journal of Nuclear Medicine. 2023 May 1;64(5):738-43.
Suzuki A, Kashiwagi N, Doi H, Ishii K, Doi K, Kitano M, Kozuka T, Hyodo T, Tsurusaki M, Yagyu Y, Nakanishi K. Patterns of bone metastases from head and neck squamous cell carcinoma. Auris Nasus Larynx. 2020 Apr 1;47(2):262-7.
Tarin D. Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance. InSeminars in cancer biology 2011 Apr 1 (Vol. 21, No. 2, pp. 72-82). Academic Press.
Thammaroj P, Chimcherd A, Chowchuen P, Panitchote A, Sumananont C, Wongsurawat N. Imaging features of bone metastases from cholangiocarcinoma. European Journal of Radiology. 2020 Aug 1;129:109118.
Zhu M, Liu X, Qu Y, Hu S, Zhang Y, Li W, Zhou X, Yang H, Zhou L, Wang Q, Hou Y. Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis. Journal of bone oncology. 2019 Apr 1;15:100219.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2023 M.Hassan Shahzad, M. Raheel Kamran, Ayesha Imtiaz , Sana Shahzadi, Sumiya Abid, Areeba Ikram